Streetbeat News

Products Services

ONCY

Oncolytics has updated its pancreatic cancer program for Pelareorep. The company, in collaboration with The Pancreatic Cancer Action Network (PanCAN), had initially planned to initiate a Phase 3 trial using the Precision Promise platform in H1 2024. However, Oncolytics now plans to conduct an adaptive Phase 3 program and manage it directly within its Clinical Group and a contract research organization, with the goal of enrolling the first patient in mid-2024.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 11:35 am

HCM

TAK

Hutchmed's partner Takeda has received FDA approval for Fruzaqla (Fruquintinib) for previously treated metastatic colorectal cancer patients. The approval was received under priority review over 20 days ahead of the scheduled Prescription Drug Users Fee.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 11:26 am

MSFT

QCOM

TMUS

The Humane AI Pin, an AI-powered device, is set to cost $699 with a $24 monthly subscription. The device operates on a Humane-branded version of T-Mobile US Inc.'s network and uses AI models from Microsoft Corp. and OpenAI. It is powered by a custom-designed processor for wearables from Qualcomm Inc. The AI Pin can draft messages, summarize emails, translate languages, identify food for nutritional data, and support Tidal music streaming.

Portfolio Pulse from Rounak Jain

November 09, 2023 | 11:21 am

GDRX

GoodRx reported that it ended Q3 with over 7 million consumers of its prescription-related offerings.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 11:19 am

WISA

WiSA Technologies, a division of Summit Wireless Technologies, has launched Platin Audio's first-ever soundbar, which is also the first in the industry to use WiSA E wireless software. This new product could potentially increase the market share and revenue of Summit Wireless Technologies.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 11:05 am

GOOG

TSLA

Alphabet's autonomous driving technology unit, Waymo, is facing criticism for its post-collision responses. A social media user posted a video showing a Waymo vehicle obstructing emergency responders, highlighting the need for autonomous vehicles to react to unexpected scenarios. Tesla CEO Elon Musk agreed, stating that advanced AI is needed for real-world driving. Waymo responded that the video was old and that it has made significant improvements since then. This comes as Cruise, another autonomous vehicle company, issued a recall for a subsystem within its automated driving systems due to issues with its post-collision response.

Portfolio Pulse from Anan Ashraf

November 09, 2023 | 11:03 am

ACHR

Archer Aviation Inc. (NYSE:ACHR) has signed a memorandum of understanding with InterGlobe Enterprises to launch an all-electric air taxi service in India by 2026. The partnership plans to finance the purchase of up to 200 of Archer's Midnight aircraft for the India operations. The companies also plan to collaborate with local business partners to manage operations, fund and construct vertiport infrastructure, and provide training for pilots and other essential personnel.

Portfolio Pulse from Nabaparna Bhattacharya

November 09, 2023 | 10:55 am

ACHR

Archer Aviation has signed a Memorandum of Understanding with InterGlobe Enterprises to launch and operate an all-electric air taxi service in India.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 10:02 am

AZN

AstraZeneca announced positive results from the EMERALD-1 Phase III trial of its drug Imfinzi in combination with transarterial chemoembolisation (TACE) and bevacizumab for liver cancer. The trial showed a significant improvement in progression-free survival (PFS) versus TACE alone.

Portfolio Pulse from Charles Gross

November 09, 2023 | 9:54 am

FXI

NVDA

Nvidia is planning to release three new chips for the Chinese market, according to a report by STAR Market Daily cited by Reuters.

Portfolio Pulse from Charles Gross

November 09, 2023 | 9:49 am